Accolade Stock

Accolade EV/FCF

Delisted·Apr 7, 2025

The EV/FCF (Enterprise Value to Free Cash Flow) of Accolade (ACCD) as of Aug 7, 2026 is -11.82. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -11.21 — a change of 5.40% (lower).

EV/FCF

-11.82

YoY

5.40%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Accolade is 2026 -11.82 . EV/FCF (Enterprise Value to Free Cash Flow) of Accolade was 2025 -11.21 . It decreases by 5.40% lower compared to the previous year.
Access this data via the Eulerpool API

Accolade Stock analysis

What does Accolade do? Accolade Inc is a US-American company based in Seattle. The company was founded in 2007 by Rajeev Singh and Mike Hilton and has since developed into a leading healthcare consulting firm. Accolade aims to make healthcare simple and affordable for everyone. The company offers a wide range of solutions to its customers. It provides services to employers, insurance companies, and health authorities. Their main focus is on supporting patients and employees in their healthcare. They also offer services to health insurance companies and health authorities. The business model of Accolade involves close collaboration between the customers and the company. Patients are supported by a "Health Assistant," who are trained professionals that help patients make the best decisions regarding their health. Factors such as finding the best providers, medication delivery, clinical tests, and alternative options are considered. Accolade's mission is to improve healthcare for everyone by providing the best solutions. The company has divided itself into several different divisions to offer its services more effectively. The various divisions of Accolade include healthcare consulting, medication management, patient access and health navigation, client support, and health optimization. Accolade has become an important healthcare service provider and has earned a good reputation in the industry. The company is known for providing comprehensive and high-quality services that focus on individual patient care. When it comes to achieving improvements in care and the entire healthcare system, Accolade is an important partner that helps companies and individuals achieve their goals and lead healthier lives. Accolade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accolade stock

EV/FCF (Enterprise Value to Free Cash Flow) of Accolade is -11.82 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Accolade changed from -11.21 to -11.82, representing a 5.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Accolade since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Accolade with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Accolade

All Key Metrics — Accolade